President establishes commission to review federal response to opioid crisis
President Trump yesterday issued an establishing a commission to study the scope and effectiveness of the federal response to drug addiction and the opioid crisis, and make recommendations to him for improving the response. The executive order calls for the commission to submit interim recommendations within 90 days and final recommendations by Oct. 1, unless the chair requests an extension. The commission will be administered by the Office of National Drug Control Policy, and its members and chair appointed by President Trump.
Related News Articles
Headline
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class non-opioid drug, to treat moderate to…
Headline
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage,…
Headline
In this conversation, Matthew Hoag, director of integrated behavioral health at Denver Health, shares how the organization is innovating through integration to…
Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…